Navigation Links
MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
Date:9/23/2009

ATLANTA, Sept. 23 /PRNewswire/ -- MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics. These devices range from spinal cages to suture anchors and across all sectors of orthopedics. As a material, PEEK provides excellent benefits such as strength, radiolucency and reliability.

"PEEK Altera(TM) is a proprietary shape memory material that will allow us to develop devices that will be 'dynamic' in nature versus the current PEEK technology which is 'static'," stated Chris Fair, MedShape Solutions' COO. The Morphix(TM) Suture Anchor system design takes advantage of the shape memory material and provides the clinician with superior fixation strength both in pull out as well as improved performance under cyclic loading. "Shape memory allows us to design and develop implants that can enter a cavity or bony tunnel in one diameter and deploy them to a much larger size. This shape change can drastically improve the strength profile of the device as well as improve the delivery environment. As an example, our 3.5mm Morphix(TM) device has a greater strength profile than most 5.5mm devices currently in the market," stated Ken Gall, PhD, founder and CTO of MedShape Solutions.

"What is unique about the Morphix(TM) device is the simplicity of its design coupled with outstanding performance when compared to competitive devices," stated orthopedic surgeon Bill Bryan, MD, Houston, TX. "I love the fact that the dynamic nature of the implant allows it to adjust to the surrounding changes in the bone that occur after cyclic loading. The Morphix(TM) is the only implant I am aware of that can do this."

MedShape Solutions also announced that it has recently closed approximately $10M of equity funding from various qualified private investors. "This recent round of financing will allow MedShape to bring forward several unique shape memory orthopedic devices that will improve patient outcomes and improve surgical procedures," stated Kurt Jacobus, PhD, President & CEO. "We continue to make progress in building a company of significant value centered around our shape memory technology platform."

Contact: Chris Fair, Chief Operating Officer, 404-249-9155, chris.fair@medshapesolutions.com

About MedShape Solutions, Inc.:

MedShape Solutions, Inc. is a privately held medical device company based in Atlanta, GA. MedShape Solutions is committed to creating and delivering unique shape memory based technologies in the field of orthopedics and to Shaping the Future of Orthopedics(TM). More information can be found at www.medshapesolutions.com


'/>"/>
SOURCE MedShape Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
2. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
3. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
4. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
5. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
6. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
7. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
8. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
9. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
10. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
11. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 Australian-US drug discovery and development company, ... appointment of a new Chairman, Mr John O,Connor , ... immediately. James Garner , has also been ... former Acting CEO, Mr Iain Ross , will resume ... --> James Garner , has also been formally appointed ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... latest GC-MS and triple quad LC-MS, host live demos and poster sessions, and ... conference and exhibition. The conference takes place March 6 to 10 at the ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology:
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
Breaking Biology News(10 mins):